ConvaTec, ett av Nordic Capital Fund VII ägt bolag, har noterats på London Stock Exchange

Medical products and technologies group ConvaTec Group Plc ("ConvaTec") has today announced the successful listing of its shares on the London Stock Exchange.

The company saw strong demand for its shares from a broad global investor base and the offering was substantially oversubscribed. The market capitalisation of ConvaTec based on the IPO price of 2.25 GBP per share is approximately GBP 4.4 billion. Nordic Capital Funds VI and VII will remain significant shareholders in the listed company.